Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma lipoprotein(a) levels in patients with homozygous autosomal dominant hypercholesterolemia.

Journal of clinical lipidology - 1 Jan 2000

Sjouke Barbara, Yahya Reyhana, Tanck Michael W T, Defesche Joep C, de Graaf Jacqueline, Wiegman Albert, Kastelein John J P, Mulder Monique T, Hovingh G Kees, Roeters van Lennep Jeanine E

Abstract excerpt

BACKGROUND: Patients with autosomal dominant hypercholesterolemia (ADH), caused by mutations in either low-density lipoprotein receptor (LDLR), apolipoprotein B (APOB), or proprotein convertase subtilisin-kexin type 9 (PCSK9) are characterized by high low-density lipoprotein cholesterol levels and in some studies also high lipoprotein(a) (Lp(a)) levels were observed. The question remains whether this effect on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to APOB gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to PCSK9 gene

Share to Homozygote

Share to Hyperlipoproteinemia Type II

Share to Lipoproteins

Share to Mutation

Share to Young Adult

Source

Identifiers

PMID: 28502508
DOI: 10.1016/j.jacl.2017.02.010

Genes

APOB
LDLR
PCSK9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma lipoprotein(a) levels in patients with homozygous autosomal dominant hypercholesterolemia.PMID 28502508Read ↗

Lipoprotein(a) in homozygous familial hypercholesterolemia.Semantic proximity Read ↗

Lipoprotein(a) in hereditary hypercholesterolemia: Influence of the genetic cause, defective gene and type of mutation.Semantic proximity Read ↗

Do genetically determined very high and very low LDL levels contribute to Lp(a) plasma concentration?Semantic proximity Read ↗

Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.Semantic proximity Read ↗

Molecular spectrum of autosomal dominant hypercholesterolemia in France.Semantic proximity Read ↗

Genome-Wide Association Study Highlights APOH as a Novel Locus for Lipoprotein(a) Levels-Brief Report.Semantic proximity Read ↗

Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations.Semantic proximity Read ↗

Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome.Semantic proximity Read ↗

Concentrations of the atherogenic Lp(a) are elevated in FH.Semantic proximity Read ↗

Apolipoprotein E phenotype and lipoprotein(a) in familial hypercholesterolaemia: implication for lipoprotein(a) metabolism.Semantic proximity Read ↗

Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia.Semantic proximity Read ↗

Lp(a) concentrations are related to plasma lipid concentrations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.